Lipoprotein glomerulopathy: genes and variants

Lipoprotein glomerulopathy is linked to 1 analyzed protein (APOE). 2 DNA variants are known to cause it; 4 more are uncertain, and 0 of those already look disease-causing on computable evidence.

Last updated 2026-09-30. Research information, not medical advice.

Genes linked to Lipoprotein glomerulopathy

Known disease-causing variants in Lipoprotein glomerulopathy

VariantPositionProtein partClinical label
APOE R43C43Disease-causing (★★)
APOE R163P1634Disease-causing

Same protein, different disease

Diseases related to Lipoprotein glomerulopathy

Frequently asked questions

Which genes are linked to Lipoprotein glomerulopathy?

In CATVariant, Lipoprotein glomerulopathy is linked to 1 analyzed protein: APOE (Apolipoprotein E).

How many genetic variants are linked to Lipoprotein glomerulopathy?

6 variants: 2 are classified as disease-causing (pathogenic or likely pathogenic) in ClinVar and 4 are of uncertain significance or have conflicting reports.

Which uncertain variants in Lipoprotein glomerulopathy look disease-causing?

None of the uncertain variants currently reaches the likely-pathogenic range on computable evidence alone.

About this data

Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from the latest public CATVariant analysis of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.

Download every variant as CSV · Browse all diseases · Methods · About the Center